4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-041312
Options or other derivatives
- Director acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BAILEY DON M Director | 2019-07-01 | Grant or award · Stock Option (Right to Buy) | −40,000 | 40,000 | D: show line 1 in the form | |||||
| BAILEY DON M Director | 2019-03-19 | Grant or award · Stock Option (Right to Buy) | −60,000 | 60,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…